Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsuhiko Murakawa is active.

Publication


Featured researches published by Katsuhiko Murakawa.


Clinical Cancer Research | 2004

Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer

Eiji Tamoto; Mitsuhiro Tada; Katsuhiko Murakawa; Minoru Takada; Gaku Shindo; Ken-ichi Teramoto; Akihiro Matsunaga; Kazuteru Komuro; Motoshi Kanai; Akiko Kawakami; Yoshie Fujiwara; Nozomi Kobayashi; Katsutoshi Shirata; Norihiro Nishimura; Shunichi Okushiba; Satoshi Kondo; Jun-ichi Hamada; Takashi Yoshiki; Tetsuya Moriuchi; Hiroyuki Katoh

Purpose: The purpose of this research was to identify molecular clues to tumor progression and lymph node metastasis in esophageal cancer and to test their value as predictive markers. Experimental Design: We explored the gene expression profiles in cDNA array data of a 36-tissue training set of esophageal squamous cell carcinoma (ESCC) by using generalized linear model-based regression analysis and a feature subset selection algorithm. By applying the identified optimal feature sets (predictive gene sets), we trained and developed ensemble classifiers consisting of multiple probabilistic neural networks combined with AdaBoosting to predict tumor stages and lymph node metastasis. We validated the classifier abilities with 18 independent cases of ESCC. Results: We identified 71 genes of 1289 cancer-related genes of which the expression correlated with tumor stages. Of the 71 genes, 47 significantly differed between the Tumor-Node-Metastasis pT1/2 and pT3/4 stages. Cell cycle regulators and transcriptional factors possibly promoting the growth of tumor cells were highly expressed in the early stages of ESCC, whereas adhesion molecules and extracellular matrix-related molecules possibly promoting invasiveness increased in the later stages. For lymph node metastasis, we identified 44 genes with predictive values, which included cell adhesion molecules and cell membrane receptors showing higher expression in node-positive cases and cell cycle regulators and intracellular signaling molecules showing higher expression in node-negative cases. The ensemble classifiers trained with the selected features predicted tumor stage and lymph node metastasis in the 18 validation cases with respective accuracies of 94.4% and 88.9%. This demonstrated the reproducibility and predictive value of the identified features. Conclusion: We suggest that these characteristic genes will provide useful information for understanding the malignant nature of ESCC as well as information useful for personalizing the treatments.


International Journal of Surgery Case Reports | 2014

Surgical resection of colorectal recurrence of gastric cancer more than 5 years after primary resection.

Takehiro Noji; Yoshiyuki Yamamura; Jun Muto; Aki Kuroda; Junkichi Koinuma; Tatsuya Yoshioka; Katsuhiko Murakawa; Setsuyuki Otake; Satoshi Hirano; Koichi Ono

INTRODUCTION Intestinal metastasis from gastric cancer is rare, although the most common cause of secondary neoplastic infiltration of the colon is gastric cancer. However, little data is available on recurrence or death in patients with gastric cancer surviving >5 years post-gastrectomy. Here we report two cases of lower intestinal metastasis from gastric cancer >5 years after primary resection and discuss with reference to the literature. PRESENTATION OF CASE Case 1: A 61-year-old man with a history of total gastrectomy for gastric cancer 9 years earlier was referred to our hospital with constipation and abdominal distention. We diagnosed primary colon cancer and subsequently performed extended left hemicolectomy. Histological examination revealed poorly differentiated adenocarcinoma resembling the gastric tumor he had 9 years earlier. The patient refused postoperative adjuvant chemotherapy and remained alive with cancerous peritonitis and skin metastases as of 17 months later. Case 2: A 46-year-old woman with a history of total gastrectomy for gastric cancer 9 years earlier presented with constipation. She also had a history of Krukenberg tumor 3 years earlier. We diagnosed metastatic rectal cancer and subsequently performed low anterior resection and hysterectomy. Pathological examination revealed poorly differentiated tubular adenocarcinoma, resembling the gastric tumor. The patient remained alive without recurrence as of 17 months later. DISCUSSION We found 19 reported cases of patients with resection of colon metastases from gastric cancer. Median disease-free interval was 74 months. CONCLUSION Resection of late-onset colorectal recurrence from gastric cancer appears worthwhile for selected patients.


Surgery Today | 1999

A case of pseudosarcoma associated with type 3 squamous cell carcinoma of the esophagus: report of a case.

Suguru Kubota; Takayuki Morita; Katsuhiko Murakawa; Yasuhiro Hida; Yuji Miyasaka; Miyoshi Fujita; Hiroaki Suzuki; Toshiji Motohara; Hiroyuki Kato

A case of a primary esophageal pseudosarcoma associated with an independent type 3 tumor is described herein. A 60-year-old male presented with dysphagia and chest discomfort. A clinical evaluation revealed a type 3 tumor in the middle of the esophagus, which was diagnosed after a biopsy to be squamous cell carcinoma (SCC). A subsequent gross examination of the subtotally removed esophagus revealed a polypoid tumor adjacent to the type 3 tumor. Histologically, the polypoid mass was composed of SCC and mesenchymal components without a transitional zone. The tumor was thus classified as a pseudosarcoma of the esophagus, and was unique in that this appeared to have developed independently from the SCC.


Langenbeck's Archives of Surgery | 2018

Circular versus linear stapling in esophagojejunostomy after laparoscopic total gastrectomy for gastric cancer: a propensity score-matched study

Noriaki Kyogoku; Yuma Ebihara; Toshiaki Shichinohe; Fumitaka Nakamura; Katsuhiko Murakawa; Takayuki Morita; Shunichi Okushiba; Satoshi Hirano

PurposeWe used propensity score matching to compare the complication rates after laparoscopic total gastrectomy (LTG) with esophagojejunostomy (EJS) performed using a circular or a linear stapler.MethodsWe retrospectively enrolled all patients who underwent curative LTG between November 2004 and March 2016. Patients were categorized into the circular and linear groups according to the stapler type used for the subsequent EJS. Patients in the groups were matched using the following propensity score covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, and Japanese Classification of Gastric Carcinoma stage. Clinicopathological characteristics and surgical outcomes were compared.ResultsWe identified 66 propensity score-matched pairs among 379 patients who underwent LTG. There was no significant between-group difference in the median operative time, extent of lymph node dissection, number of lymph nodes resected, rate of conversion to open surgery, or number of surgeries performed by a surgeon certified by the Japanese Society of Endoscopic Surgery. In the circular and linear groups, the rate of all complications (Clavien–Dindo [CD] classification ≥ I; 21 vs. 26%, respectively; p = 0.538), complications more severe than CD grade III (14 vs. 14%, respectively; p = 1.000), and occurrence of EJS leakage and stenosis more severe than CD grade III (5 vs. 2%, p = 0.301; 9 vs. 8%, p = 0.753, respectively) were comparable.ConclusionsThere is no difference in the postoperative complication rate related to the type of stapler used for EJS after LTG.


Asian Journal of Endoscopic Surgery | 2017

Laparoscopic segmental duodenectomy for a gastrointestinal stromal tumor located in the second portion of the duodenum: A case report

Kazufumi Umemoto; Yoshitsugu Nakanishi; Katsuhiko Murakawa; Tomohiro Suzuki; Yoshiyuki Yamamura; Koichi Ono; Satoshi Hirano

Gastrointestinal stromal tumors of the duodenum are rare. For benign tumors, premalignant lesions, or malignant potential tumors located in the second portion of the duodenum close to the papilla of Vater, pancreaticoduodenectomy is sometimes performed. A case of laparoscopic segmental duodenectomy for a gastrointestinal stromal tumor at the second portion of the duodenum is reported. The surgical procedure was performed as follows: first, the second portion of the duodenum was separated from the pancreatic head; second, the duodenum was cut off with the linear stapler after having confirmed preservation of the papilla by intraoperative endoscopy; and third, reconstruction was carried out by a side‐to‐side duodenojejunostomy. Laparoscopic segmental duodenectomy for duodenal gastrointestinal stromal tumors is thought to be advantageous compared with pancreaticoduodenectomy in terms of low burden and organ function preservation. The present procedure is feasible for benign or low‐malignant tumors that do not infiltrate outside of the duodenal walls.


Asian Journal of Endoscopic Surgery | 2017

Minimally invasive surgery for esophageal cancer after esophageal perforation: Esophageal cancer after perforation

Katsuhiko Murakawa; Koichi Ono; Yoshiyuki Yamamura; Hiroki Niwa; Hiroyuki Yamamoto; Jun Muto; Kohei Kato; Masaomi Ichinokawa; Tatsuya Yoshioka; Setsuyuki Ohtake

Both esophageal rupture and esophageal cancer are life‐threatening diseases. We report a case of esophageal cancer that occurred after esophageal rupture was treated with thoracoscopic and laparoscopic surgery. A 76‐year‐old man presented with vomiting followed by epigastric pain and was diagnosed with spontaneous esophageal rupture. Laparoscopic and thoracoscopic surgery were performed. Primary closure was completed with a fundic patch, and thoracic lavage was performed. Ten months later, his condition was diagnosed as squamous cell carcinoma of the abdominal esophagus. He underwent thoracoscopic esophageal resection in the prone position, and a gastric conduit was created laparoscopically. The pathological finding was superficial esophageal carcinoma without lymph node metastasis. The patients postoperative course was uneventful, and there was no recurrence at 21 months of follow‐up.


Experimental Cell Research | 2004

Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system.

Yoko Takahashi; Jun-ichi Hamada; Katsuhiko Murakawa; Minoru Takada; Mitsuhiro Tada; Ikuko Nogami; Nobuyasu Hayashi; Shoji Nakamori; Morito Monden; Masaki Miyamoto; Hiroyuki Katoh; Tetsuya Moriuchi


Oncology Reports | 2005

Aberrant expression of HOX genes in human invasive breast carcinoma

Kokonoe Makiyama; Jun-ichi Hamada; Minoru Takada; Katsuhiko Murakawa; Yoko Takahashi; Mitsuhiro Tada; Eiji Tamoto; Gaku Shindo; Akihiro Matsunaga; Ken Ichi Teramoto; Kazuteru Komuro; Satoshi Kondo; Hiroyuki Katoh; Takao Koike; Tetsuya Moriuchi


Journal of Surgical Research | 2004

Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis

Kazuteru Komuro; Mitsuhiro Tada; Eiji Tamoto; Akiko Kawakami; Akihiro Matsunaga; Ken-ichi Teramoto; Gaku Shindoh; Minoru Takada; Katsuhiko Murakawa; Motoshi Kanai; Nozomi Kobayashi; Yoshie Fujiwara; Norihiro Nishimura; Jun-ichi Hamada; Akihiro Ishizu; Hitoshi Ikeda; Satoshi Kondo; Hiroyuki Katoh; Tetsuya Moriuchi; Takashi Yoshiki


Oncology Reports | 2010

Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas

Motoshi Kanai; Jun-ichi Hamada; Minoru Takada; Toshimichi Asano; Katsuhiko Murakawa; Yoko Takahashi; Taichi Murai; Mitsuhiro Tada; Masaki Miyamoto; Satoshi Kondo; Tetsuya Moriuchi

Collaboration


Dive into the Katsuhiko Murakawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoshi Hirano

Nagoya Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge